Skip to content
Open access

PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation

Sep 2026 · Journal of Nuclear Medicine · Vol 67, pp. 1771 - 1776 · 0 citations · 35 references
Medicine

TL;DR

The dynamic changes of CD163-positive TAMs in HNSCC progression and treatment response were determined to assess the potential of a CD163 targeted radiotracer, 64Cu-ICT-01, in detecting CD163-positive TAMs for translation in HNSCC.

Abstract

Visual Abstract Tumor-associated macrophages (TAMs) are an important component of the tumor microenvironment (TME). The abundance and distribution of TAMs significantly affect the immune responses of TME to determine the tumor progression and treatment response of solid tumors such as head and neck squamous cell carcinoma (HNSCC). Molecular characterization of human HNSCC specimens and mouse models has identified CD163 as a unique biomarker for TAMs in HNSCC. The goal of this study was to determine the dynamic changes of CD163-positive TAMs in HNSCC progression and treatment response to assess the potential of a CD163 targeted radiotracer, 64Cu-ICT-01, in detecting CD163-positive TAMs for translation in HNSCC. Methods: We assessed the capability of 64Cu-ICT-01 for noninvasive imaging of CD163-positive TAMs using PET. We determined its targeting specificity in multiple mouse HNSCC models to track the progression of tumors. We assessed its sensitivity in tracking variations of CD163-positive TAMs and correlation with tumor volumes after clinical treatment. We also measured its binding to CD163-positive TAMs upregulated on human HNSCC tissues. Results: 64Cu-ICT-01 PET specifically determined the spatiotemporal distribution of CD163-positive TAMs in a MOC1 cell line model and patient-derived xenograft HNSCC models. CD163 PET sensitively tracked the dynamics of CD163-positive TAMs after clinical treatment. Its tumor binding correlated with CD163 expression levels and the volumes of tumors. In human HNSCC specimens, 64Cu-ICT-01 showed strong and specific binding to human CD163. Conclusion: 64Cu-ICT-01 demonstrated accurate targeting of CD163 in both mouse tumor models and human HNSCC tissues. CD163 PET has great potential to be a noninvasive biomarker to measure TAM activities within TME, monitor treatment response, and optimize treatment strategy.

Read PDF

Similar papers

Open access Sep 2026

A FABulous approach to image human macrophages

Imaging tumor-associated macrophages (TAMs) may reflect prognosis, therapeutic response and radiotheranostic potential. We report the discovery and development of a synthetic human Fab as the first immunoPET tracer targeting human CD68 (huCD68), the gold standard histopathological biomarker of pan-macrophages. Phage di...

Borna Roohani, Ayla Vaughn Embs, Robin Kumar et al. · 0 citations
Review Open access Nov 2026

The Role of Tumor-Associated Macrophages in Lung Cancer Progression and Therapy: From Mechanistic Insights to Targeting Strategies

Abstract Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the lung cancer tumor microenvironment (TME), where their functions vary according to developmental origin, local signals, metabolic conditions, spatial location, and treatment exposure. The conventional M1 and M2 framework therefo...

Jia-Cheng Sun, Ying Liu, Hua-Lin Sun et al. · 0 citations
Review Open access Oct 2026

Spatial Characteristics of the Immune Microenvironment in Brain Metastases Provide Critical Insights for Developing Predictive Markers for Anti-PD-1 Therapy

Brain metastases (BrM) exhibit variable intracranial responses to immune checkpoint blockade (ICB), and reliable biomarkers of benefit remain uncertain, possibly reflecting the distinctive brain microenvironment. This review discusses multiplex protein imaging, array-based spatial transcriptomics, and in situ RNA imagi...

Xiu-Qi Wang, Zhen-Yu Yang · 0 citations
Open access Oct 2026

Temporal mapping of the anti-tumor effects of nanobody-based MSLN.CAR-T cell therapy in metastatic solid tumors

Studies on the dynamic changes occurring in the tumor microenvironment (TME) following CAR-T cell therapy have been confounded by host lymphodepletion, multiple dosing and immunodeficient models. Therefore, CAR-T cell mediated changes in the TME contributing to solid tumor resistance to CAR-T cell therapy remain poor...

Chaido Stathopoulou, Ming-Ming Zhao, Qun Jiang et al. · 0 citations
Open access 2022

Molecular Identity Changes of Tumor-Associated Macrophages and Microglia after MRgFUS induced BBB Opening in a Mouse Glioblastoma Model

Abstract An orthotopically xenografted mouse GL26 glioma model (Ccr2RFP/wt-Cx3cr1GFP/wt) was used to evaluate the effect of transient, focal opening of the Blood Brain Barrier (BBB) on the composition of tumor-associated macrophages and microglia (TAMs). Opening of the BBB was induced by Magnetic Resonance Imaging (MRI...

Yan-Rong Zhang, Jing Wang, Sara Natasha Ghobadi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.